Klinikum Westbrandenburg

Yayınlar

Yazar kurumunda bu kurumu belirten bilimsel yayınlar: 65 · başlangıç 2016

Yazar bağlantısına göre uzmanlık yayınları – tedavi başarısı veya kurumun kalitesi hakkında bir beyan değildir. MedVici Health şu anda kanserle ilgili yayınları göstermemektedir.

En yeniler:

• Long-Term Antibiotic Use and Accumulation of Antimicrobial Resistance Genes in the Microbiome? Insights from a Cystic Fibrosis CohortPneumologie · 2026
• Relating Improvement in Gastrointestinal (CFAbd-Score©) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF PatientsPediatric pulmonology · 2026
• Dietary recommendations for people with cystic fibrosis, a relevantly changing fieldJornal de pediatria · 2026
• The validated French CFAbd-Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/IvacaftorJournal of pediatric gastroenterology and nutrition · 2025
• The novel CFAbd-Score.kidⒸ reveals a significant decline of abdominal symptoms in children with Cystic fibrosis aged 6 through 11 years on Elexacaftor/Tezacaftor/Ivacaftor - first resultsJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
• Impact of Antibiotic Therapy on the Upper Respiratory Tract and Gut Mycobiome in Patients with Cystic FibrosisJournal of fungi (Basel, Switzerland) · 2025
• Validation of the CFAbd-Score.kidⒸ, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosisJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
• Expansion of CD103+CD69+CD8+ cytotoxic liver tissue resident memory T cells and inflammatory monocytes in advanced biliary atresiaFrontiers in immunology · 2025
• P295 Early improvement in gastro-intestinal symptoms in 2-5 year old children following the introduction of elexacaftor/ tezacaftor/ ivacaftor (ETI)Journal of Cystic Fibrosis · 2025 · Kongre bildirisi
• P294 French translation, validation and application of the CFAbd-Score© reveals a lower burden of gastrointestinal symptoms in patients treated with elexacaftor/tezacaftor/ivacaftorJournal of Cystic Fibrosis · 2025 · Kongre bildirisi

MedVici Media'daki tüm kayıtlar

Eşleştirme, yayının yazar kurum bilgisine göre yapılır. Veriler: PubMed (U.S. National Library of Medicine) ve OpenAlex. Liste ne kurumu ne de tedavilerini değerlendirir.